Chattem
This article was originally published in The Tan Sheet
Executive Summary
Completes acquisition of Procter & Gamble's Benzodent denture analgesic cream, which has annual sales of about $2 mil. Terms of the deal were not disclosed. Chattem said the acquisition complements its specialty analgesics offerings such as the Flex- All and Icy Hot topical analgesics and the Pamprin and Premsyn menstrual analgesics. Chattem announced the negotiations in April ("The Tan Sheet" April 18, In Brief)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning